We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+37.58%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$10.5B
AUM Growth
+$2.1B
Cap. Flow
-$429M
Cap. Flow %
-4.09%
Top 10 Hldgs %
13.09%
Holding
245
New
23
Increased
75
Reduced
125
Closed
18

Top Buys

Rank Stock Value
1
NEWR
New Relic, Inc.
NEWR
+$64.1M
2
BILL icon
BILL Holdings
BILL
+$53.1M
3
IMMU
Immunomedics Inc
IMMU
+$52.9M
4
ATRC icon
AtriCure
ATRC
+$51.2M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$49.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$120M
2
CBRE icon
CBRE Group
CBRE
+$89.6M
3
CHGG icon
Chegg
CHGG
+$66M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.2M
5
DOX icon
Amdocs
DOX
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 31.1%
2 Healthcare 19.47%
3 Industrials 14.73%
4 Consumer Discretionary 9.8%
5 Financials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BR icon
151
Broadridge
BR
$19.1B
$31.1M 0.3%
246,500
-101,500
-29% -$11.8M
SIGI icon
152
Selective Insurance
SIGI
$5.38B
$31.1M 0.3%
589,340
+361,650
+159% +$18.3M
CLVT icon
153
Clarivate
CLVT
$1.2B
$30.4M 0.29%
1,362,100
+414,800
+44% +$9.37M
SIVB
154
DELISTED
SVB Financial Group
SIVB
$29.9M 0.29%
138,900
-37,700
-21% -$7.26M
BFAM icon
155
Bright Horizons
BFAM
$3.17B
$29.8M 0.28%
254,500
+60,700
+31% +$6.93M
CCOI icon
156
Cogent Communications
CCOI
$478M
$29.3M 0.28%
379,080
-111,040
-23% -$8.99M
AZEK
157
DELISTED
The AZEK Co
AZEK
$27.1M 0.26%
+850,000
New +$25.8M
CHGG icon
158
Chegg
CHGG
$81.6M
$26.6M 0.25%
395,000
-1,235,185
-76% -$66M
ATR icon
159
AptarGroup
ATR
$7.94B
$25.6M 0.24%
228,300
+30,000
+15% +$3.19M
CRSP icon
160
CRISPR Therapeutics
CRSP
$5.12B
$25.1M 0.24%
340,950
-22,400
-6% -$1.31M
ITT icon
161
ITT
ITT
$18.3B
$24.7M 0.24%
420,100
-47,100
-10% -$2.5M
GNTX icon
162
Gentex
GNTX
$4.8B
$24.5M 0.23%
950,000
+310,200
+48% +$7.77M
AZTA icon
163
Azenta
AZTA
$1.4B
$24.5M 0.23%
552,740
-26,400
-5% -$1.01M
BBIO icon
164
BridgeBio Pharma
BBIO
$14.1B
$23.4M 0.22%
718,629
+230,979
+47% +$7.04M
HMSY
165
DELISTED
HMS Holdings Corp.
HMSY
$23.4M 0.22%
723,090
+578,600
+400% +$16.7M
PFGC icon
166
Performance Food Group
PFGC
$14.8B
$23.2M 0.22%
795,500
+30,200
+4% +$785K
SBNY
167
DELISTED
Signature Bank
SBNY
$23.1M 0.22%
215,700
+55,700
+35% +$5.48M
CYRX icon
168
CryoPort
CYRX
$788M
$22.9M 0.22%
758,400
-683,516
-47% -$15.2M
NSTG
169
DELISTED
NanoString Technologies, Inc.
NSTG
$22.8M 0.22%
776,955
-14,880
-2% -$443K
MBUU icon
170
Malibu Boats
MBUU
$490M
$22.5M 0.22%
434,060
-195,985
-31% -$7.83M
RCUS icon
171
Arcus Biosciences
RCUS
$3.06B
$21.9M 0.21%
+884,870
New +$23.9M
BEST
172
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$21.1M 0.2%
246,355
-91,360
-27% -$9.38M
LASR icon
173
nLIGHT
LASR
$2.33B
$20.8M 0.2%
933,100
-147,535
-14% -$2.79M
QTNT
174
DELISTED
Quotient Limited Ordinary Shares
QTNT
$20.6M 0.2%
69,758
-3,310
-5% -$953K
RST
175
DELISTED
ROSETTA STONE INC
RST
$20M 0.19%
1,188,460
-138,200
-10% -$2.32M
5 6
7
8 9

Similar funds

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

TimesSquare Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, TimesSquare Capital Management held 245 positions worth $10.5B, up 25% from $8.39B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TimesSquare Capital Management withdrew a net $429M in Q2 2020, closing 18 positions and reducing 125 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $56.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, TimesSquare Capital Management opened a new position in Immunomedics Inc worth $64.2M.

  • TimesSquare Capital Management's largest Q2 2020 buy was Immunomedics Inc: 1,811,000 shares worth $64.2M.
  • TimesSquare Capital Management added most to New Relic, Inc. in Q2 2020, an estimated $64.1M increase.
  • TimesSquare Capital Management's biggest Q2 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $120M.
  • TimesSquare Capital Management fully exited Alexion Pharmaceuticals in Q2 2020, selling an estimated $56.2M.
  • TimesSquare Capital Management's ten largest holdings make up 13% of its $10.5B portfolio in Q2 2020.
  • TimesSquare Capital Management opened 23 new positions and closed 18 in Q2 2020.
  • TimesSquare Capital Management's portfolio value rose 25% quarter-over-quarter to $10.5B.

Based on TimesSquare Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.